Annual CFO
-$8.72 M
-$7.23 M-483.49%
December 1, 2023
Summary
- As of February 7, 2025, ZVSA annual cash flow from operations is -$8.72 million, with the most recent change of -$7.23 million (-483.49%) on December 1, 2023.
- During the last 3 years, ZVSA annual CFO has fallen by -$3.61 million (-70.67%).
- ZVSA annual CFO is now -483.49% below its all-time high of -$1.49 million, reached on December 31, 2022.
Performance
ZVSA Cash From Operations Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly CFO
-$644.40 K
+$1.27 M+66.33%
September 1, 2024
Summary
- As of February 7, 2025, ZVSA quarterly cash flow from operations is -$644.40 thousand, with the most recent change of +$1.27 million (+66.33%) on September 1, 2024.
- Over the past year, ZVSA quarterly CFO has increased by +$3.13 million (+82.94%).
- ZVSA quarterly CFO is now -104.25% below its all-time high of -$315.50 thousand, reached on June 1, 2022.
Performance
ZVSA Quarterly CFO Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM CFO
-$9.12 M
+$292.00 K+3.10%
September 1, 2024
Summary
- As of February 7, 2025, ZVSA TTM cash flow from operations is -$9.12 million, with the most recent change of +$292.00 thousand (+3.10%) on September 1, 2024.
- Over the past year, ZVSA TTM CFO has dropped by -$1.21 million (-15.36%).
- ZVSA TTM CFO is now -2339.17% below its all-time high of -$374.00 thousand, reached on March 1, 2022.
Performance
ZVSA TTM CFO Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Cash From Operations Formula
CFO = Net Income + Non Cash Expenses + Changes In Working Capital
ZVSA Cash From Operations Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -483.5% | +82.9% | -15.4% |
| 3 y3 years | -70.7% | -104.3% | -1223.1% |
| 5 y5 years | -70.7% | -104.3% | -1223.1% |
ZVSA Cash From Operations Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -483.5% | at low | -104.3% | +86.0% | -2339.2% | +3.1% |
| 5 y | 5-year | -483.5% | at low | -104.3% | +86.0% | -2339.2% | +3.1% |
| alltime | all time | -483.5% | at low | -104.3% | +86.0% | -2339.2% | +3.1% |
ZyVersa Therapeutics Cash From Operations History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2024 | - | -$644.40 K(-66.3%) | -$9.12 M(-3.1%) |
| Jun 2024 | - | -$1.91 M(-49.3%) | -$9.41 M(+19.1%) |
| Mar 2024 | - | -$3.78 M(+35.5%) | -$7.91 M(-9.3%) |
| Dec 2023 | -$8.72 M | -$2.79 M(+197.7%) | -$8.72 M(+37.3%) |
| Sep 2023 | - | -$936.40 K(+129.7%) | -$6.35 M(+9.4%) |
| Jun 2023 | - | -$407.60 K(-91.1%) | -$5.80 M(+1.6%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2023 | - | -$4.59 M(+1002.5%) | -$5.71 M(+282.0%) |
| Dec 2022 | -$1.49 M(-70.6%) | -$416.30 K(+7.0%) | -$1.49 M(+38.6%) |
| Sep 2022 | - | -$388.90 K(+23.3%) | -$1.08 M(+56.4%) |
| Jun 2022 | - | -$315.50 K(-15.6%) | -$689.50 K(+84.4%) |
| Mar 2022 | - | -$374.00 K | -$374.00 K |
| Dec 2021 | -$5.08 M(-0.7%) | - | - |
| Dec 2020 | -$5.11 M | - | - |
FAQ
- What is ZyVersa Therapeutics annual cash flow from operations?
- What is the all time high annual CFO for ZyVersa Therapeutics?
- What is ZyVersa Therapeutics annual CFO year-on-year change?
- What is ZyVersa Therapeutics quarterly cash flow from operations?
- What is the all time high quarterly CFO for ZyVersa Therapeutics?
- What is ZyVersa Therapeutics quarterly CFO year-on-year change?
- What is ZyVersa Therapeutics TTM cash flow from operations?
- What is the all time high TTM CFO for ZyVersa Therapeutics?
- What is ZyVersa Therapeutics TTM CFO year-on-year change?
What is ZyVersa Therapeutics annual cash flow from operations?
The current annual CFO of ZVSA is -$8.72 M
What is the all time high annual CFO for ZyVersa Therapeutics?
ZyVersa Therapeutics all-time high annual cash flow from operations is -$1.49 M
What is ZyVersa Therapeutics annual CFO year-on-year change?
Over the past year, ZVSA annual cash flow from operations has changed by -$7.23 M (-483.49%)
What is ZyVersa Therapeutics quarterly cash flow from operations?
The current quarterly CFO of ZVSA is -$644.40 K
What is the all time high quarterly CFO for ZyVersa Therapeutics?
ZyVersa Therapeutics all-time high quarterly cash flow from operations is -$315.50 K
What is ZyVersa Therapeutics quarterly CFO year-on-year change?
Over the past year, ZVSA quarterly cash flow from operations has changed by +$3.13 M (+82.94%)
What is ZyVersa Therapeutics TTM cash flow from operations?
The current TTM CFO of ZVSA is -$9.12 M
What is the all time high TTM CFO for ZyVersa Therapeutics?
ZyVersa Therapeutics all-time high TTM cash flow from operations is -$374.00 K
What is ZyVersa Therapeutics TTM CFO year-on-year change?
Over the past year, ZVSA TTM cash flow from operations has changed by -$1.21 M (-15.36%)